Trevi Therapeutics
TRVI
#4846
Rank
A$2.72 B
Marketcap
A$21.26
Share price
8.79%
Change (1 day)
414.48%
Change (1 year)

Earnings for Trevi Therapeutics (TRVI)

Earnings in 2025 (TTM): -A$71.52 Million

According to Trevi Therapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -A$72.11 Million a decrease over its 2023 earnings that were of -A$43.18 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Trevi Therapeutics from 2018 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$71.52 Million-0.82%
2024 -A$72.11 Million67%
2023 -A$43.18 Million2.43%
2022 -A$42.16 Million-14.45%
2021 -A$49.28 Million1.36%
2020 -A$48.62 Million23.64%
2019 -A$39.32 Million27.54%
2018 -A$30.83 Million